STROKE PREVENTION IN THE ELDERLY

REFERENCES

• Barnett H.J. M., Eliasziw M., Meldrum H. E. The Prevention of Ischemic Stroke. BMJ 1999; 318: 1539–1543
   PubMedGoogle Scholar
• Gallai V., Caso V., Paciaroni M., Cardaioli G., Arning E., Bottiglieri T., Parnetti L. Mild Hyperhomocyst(e)inemia. A Possible Risk Factor for Cervical Artery Dissection. Stroke 2001; 32: 714–718
   PubMed Web of Science ®Google Scholar
• Taylor D. W., Barnett H.J. M., Haynes R. B., Ferguson G. G., Sackett D. L., Thorpe K. E., Simard D., Silver F. L., Hachinski V., Clagett G. P., Barnes R., Spence J. D. for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy: A Randomized Controlled Trial. Lancet 1999; 353: 2179–2184
   PubMed Web of Science ®Google Scholar
• The Steering Committee of the Physicians' Health Study Research Group: Final Report on the Aspirin Component of the Ongoing Physicians' Health Study. NEJM 1989; 321: 129–135
   PubMed Web of Science ®Google Scholar
• Hansson L., Zanchetti A., Carruthers S. G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K. H., Wedel H., Westerling S. for the HOT Study Group. Effects of Intensive Blood-Pressure Lowering and Low-Dose Aspirin in Patients with Hypertension: Principal Results of the Hypertension Optimal Treatment (HOT) Randomised Trial. Lancet 1998; 351: 1755–1762
   PubMed Web of Science ®Google Scholar
• O'Connor C., Fisher M., O'Gara P., Sutton J., Kopecky S., Harrington R. A. for the CARS Investigators. The Importance of Aspirin Dose in the Protection of Non-Hemorrhagic Stroke Following Acute Myocardial Infarction: Insights from the Coumadin Aspirin Reinfarction Study (CARS). Circulation 1996; 94(8)I-80–I-81, et al.
   Google Scholar
• The Medical Research Council's General Practice Research Framework. Thrombosis Prevention Trial: Randomised Trial of Low-Intensity Oral Anticoagulation with Warfarin and Low-Dose Aspirin in the Primary Prevention of Ischaemic Heart Disease in Men at Increased Risk. Lancet 1998; 351: 233–241
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering Committee: A Randomised, Blinded, Trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) 1996; 348: 1329–1339
   Google Scholar
• Dyken M. L. Controversies in Stroke: Past and Present. The Willis Lecture. Stroke 1993; 24: 1251–1258
   PubMed Web of Science ®Google Scholar
• Harbison J. W. for the Ticlopidine Aspirin Stroke Study Group. Ticlopidine Versus Aspirin for the Prevention of Recurrent Stroke. Analysis of Patients with Minor Stroke from the Ticlopidine Aspirin Study. Stroke 1992; 23: 1723–1727
   PubMed Web of Science ®Google Scholar
• Barnett H.J. M., Eliasziw M., Meldrum H. E. Prevention of Ischemic Stroke (Letter). NEJM 1995; 333: 460
   Web of Science ®Google Scholar
• Bennett C. L., Weinberg P. D., Rozenberg-Ben-Dror K., Yarnold P. R., Kwaan H. C., Green D. Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine. A Review of 60 Cases. Ann. Intern. Med. 1998; 128: 541–544
   PubMed Web of Science ®Google Scholar
• Bennett C. L., Connors J. M., Carwile J. M., Moake J. L., Bell W. R., Tarantolo S. R., McCarthy L. J., Sarode R., Hatfield A. J., Feldman M. D., Davidson C. J., Tsai H. M. Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel. N. Engl. J. Med. 2000; 342: 1773–1777
   PubMed Web of Science ®Google Scholar
• Diener H. C., Cunha L., Forbes C., Sivenius J., Smets P., Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and Acetylsalicylic Acid in the Secondary Prevention of Stroke. J. Neurol. Sci. 1996; 143: 1–13
   PubMed Web of Science ®Google Scholar
• Enserink M. Fraud and Ethics Charges Hit Stroke Drug Trial. Science 1996; 274: 2004–2005
   PubMed Web of Science ®Google Scholar
• Barnett H.J. M., Taylor D. W., Eliasziw M., Ferguson G. G., Haynes R. B., Rankin R. N., Clagett G. P., Hachinski V. C., Sackett D. L., Thorpe K. E., Meldrum H. E. for the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis. N. Eng. J. Med. 1998; 339: 1415–1425
   PubMed Web of Science ®Google Scholar
• European Carotid Surgery Trialists' Group. Randomised Trial of Endarterectomy for Recently Symptomatic Carotid Stenosis: Final Results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379–1387
   PubMed Web of Science ®Google Scholar
• Mayberg M. R., Wilson S. E., Yatsu F., Weiss D. G., Messina L., Hershey L. A., Colling C., Eskridge J., Deykin D., Winn H. R. for the Veterans Affairs Cooperative Studies Program 309 Trialist Group. Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis. JAMA 1991; 266: 3289–3294
   Google Scholar
• Hobson R. W., II, Weiss D. G., Fields W. S., Goldstone J., Moore W. S., Towne J. B., Wright C. B. and the Veterans Affairs Cooperative Study Group: Efficacy of Carotid Endarterectomy for Asymptomatic Carotid Stenosis. N. Engl. J. Med. 1993; 328: 221–227
   PubMed Web of Science ®Google Scholar
• The CASANOVA Study Group. Carotid Surgery Versus Medical Therapy in Asmptomatic Carotid Stenosis. Stroke 1991; 22: 1229–1235
   PubMed Web of Science ®Google Scholar
• Mayo Asymptomatic Carotid Endarterectomy Study Group. Results of a Randomized Controlled Trial of Carotid Endartrectomy for Asymptomatic Carotid Stenosis. Mayo Clin. Proc. 1992; 67: 513–518
   PubMed Web of Science ®Google Scholar
• Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for Asymptomatic Carotid Artery Stenosis. JAMA 1995; 273: 1421–1428
   PubMed Web of Science ®Google Scholar
• Nicolaides A. N. Asymptomatic Carotid Stenosis and Risk of Stroke. Identification of a High Risk Group (ACSRS). A Natural History Study. Int. Angiol. 1995; 14: 21–23
   Google Scholar
• Halliday A. W., Thomas D., Mansfield A. The Asymptomatic Carotid Surgery Trial (ACST) Rationale and Design. Eur. J. Vasc. Surg. 1994; 8: 703–710
   PubMedGoogle Scholar